Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy

Pancreatic cancer is the most common lethal tumor in America. This lethality is related to limited treatment options. Conventional treatments involve the non-specific use of chemotherapeutical agents such as 5-FU, capecitabine, gemcitabine, paclitaxel, cisplatin, oxaliplatin, or irinotecan, which pr...

Полное описание

Сохранить в:
Библиографические подробности
Другие авторы: Roacho-Pérez, Jorge A., Chapa, Christian, Garza Treviño, Elsa N., Delgado González, Paulina, G Buendeño, Zuca, Delgado Gallegos, Juan Luis, Sánchez Domínguez, Margarita, Sanchez Dominguez, Celia Nohemi, Islas, José Francisco
Формат: Artículo
Язык:en_US
Опубликовано: 2021
Предметы:
Pancreatic cancer
Cancer
Molecular markers
Target theraphy
Nanomedicine
info:eu-repo/classification/cti/2
info:eu-repo/classification/cti/3
info:eu-repo/classification/cti/7
Online-ссылка:https://doi.org/10.3390/life11111187
https://www.mdpi.com/2075-1729/11/11/1187
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы

Схожие документы